Low-Dose Aspirin Mitigates Sleep Loss-Induced Inflammation
https://reachmd.com/news/low-dose-aspirin-mitigates-sleep-loss-induced-inflammation/2466929/
DARIEN, IL – A new study to be presented at the SLEEP 2024 annual meeting found that low-dose acetylsalicylic acid, also known as aspirin, can reduce inflammatory responses to sleep restriction.Results show that compared with placebo, preemptive administration of low-dose aspirin during sleep rest…
Ethris Doses First Patient with Antiviral mRNA Drug in Phase I Asthma Trial
https://reachmd.com/news/ethris-doses-first-patient-with-antiviral-mrna-drug-in-phase-i-asthma-trial/2463243/
…
3D-Printed Grafts Revolutionize Fight Against Thrombosis, Aneurysm
https://reachmd.com/news/3d-printed-grafts-revolutionize-fight-against-thrombosis-aneurysm/2466904/
A new study presents the development of 3D printed electrospun vascular grafts infused with tetramethylpyrazine (TMP), offering a potential solution to reduce thrombosis and restrain aneurysmal dilatation post-surgery. This innovation has potential implications for improving cardiovascular disease…
Drug Shows Promise for Slowing Progression of Rare, Painful Genetic Disease
https://reachmd.com/news/drug-shows-promise-for-slowing-progression-of-rare-painful-genetic-disease/2463237/
Media AdvisoryWednesday, April 3, 2024Drug shows promise for slowing progression of rare, painful genetic disease NIH-supported clinical trial could lead to first effective treatment…
New Biomarker Diagnoses Asymptomatic Alzheimer's Stages
https://reachmd.com/news/new-biomarker-diagnoses-asymptomatic-alzheimers-stages/2463057/
A study led by the Molecular and Cellular Neurobiotechnology group at the University of Barcelona and the Institute for Bioengineering of Catalonia (IBEC) has identified a new biomarker of Alzheimer's disease in asymptomatic stages of the disease. The molecule is miR-519a-3p, a microRNA that is d…
Eye Care: Taking Electroretinography to the Next Level with a Soft Multi-Electrode System
https://reachmd.com/news/eye-care-taking-electroretinography-to-the-next-level-with-a-soft-multi-electrode-system/2463043/
Eye diseases are becoming more prevalent worldwide, partly because of the aging population, but also because of our greatly increased screen time compared to previous generations. Considering our use of displays will most likely keep rising due to technologies such as virtual and augmented reality,…
New Study Aims to Combat Sight Damage from Diabetes
https://reachmd.com/news/new-study-aims-to-combat-sight-damage-from-diabetes/2462976/
DETROIT — Fu-Shin Yu, Ph.D., professor of ophthalmology, visual and anatomical sciences in the Wayne State University School of Medicine, received an award from the National Eye Institute of the National Institutes of Health for his study aiming to reverse the adverse effects of diabetes on eyesig…
Cranberry Extracts Could Boost Microbiota and Counter Cardiometabolic Diseases
https://reachmd.com/news/cranberry-extracts-could-boost-microbiota-and-counter-cardiometabolic-diseases/2462916/
Québec, April 30, 2024 - Cranberry extracts appear to improve intestinal microbiota and help prevent chronic diseases such as diabetes and cardiovascular diseases. The study of Université Laval and the Institute of Nutrition and Functional Foods (INAF) repo…
Cleveland Clinic Study Finds Common Artificial Sweetener Linked to Higher Rates of Heart Attack and Stroke
https://reachmd.com/news/cleveland-clinic-study-finds-common-artificial-sweetener-linked-to-higher-rates-of-heart-attack-and-stroke/2462922/
New Cleveland Clinic research showed that erythritol, a popular artificial sweetener, is associated with an increased risk of heart attack and stroke. Findings were published today in Nature Medicine.Researchers studied over 4,000 people in the U.S. and Europe and found those with higher blood eryt…
Researchers Shed Light on the Molecular Causes of Different Functions of Opioid Receptors
https://reachmd.com/news/researchers-shed-light-on-the-molecular-causes-of-different-functions-of-opioid-receptors/2462722/
Ligand-dependent activation of the µOR. a, Binding of agonist to the µOR activates two downstream signaling pathways: the G-protein pathway and the β-arrestin pathway. b, The hallmark conformational change of GPCR activation i…